nach oben

Graefe's Archive for Clinical and Experimental Ophthalmology

Erschienen in:

04.01.2023 | COVID-19 | Mini Review

Retinal vascular occlusions in COVID-19 infection and vaccination: a literature review

verfasst von: Suji Yeo, Hanju Kim, Jiwon Lee, Jeonghyun Yi, Yoo-Ri Chung

Erschienen in: Graefe's Archive for Clinical and Experimental Ophthalmology | Ausgabe 7/2023

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Abnormal hypercoagulability and increased thromboembolic risk are common in patients with coronavirus disease (COVID-19). COVID-19 has been suggested to cause retinal vascular damage, with several studies on COVID-19 patients with retinal vascular occlusions. We reviewed and investigated studies on retinal vascular occlusions in patients diagnosed with COVID-19 and in those vaccinated for COVID-19.

Methods

Studies that reported retinal vascular occlusion in COVID-19 patients or in vaccinated people were identified using the terms “retinal occlusion,” together with “severe acute respiratory syndrome coronavirus 2”, “SARS-CoV-2,” “COVID-19,” “coronavirus,” and “vaccine,” through systematic searches of PubMed and Google Scholar databases until January 7, 2022.

Results

Thirteen cases of retinal artery occlusion (RAO) and 14 cases of retinal vein occlusion (RVO) were identified among patients diagnosed with COVID-19. Half of the patients with RAO or RVO revealed no systemic disorders except current or past COVID-19, and ocular symptoms were the initial presentation in five cases. Among patients with RAO, most presented with central RAO at 1–14 days of COVID-19 diagnosis, with abnormal coagulation and inflammatory markers. Among those with RVO, two-thirds presented with central RVO and one-third with RVO. Eleven cases with acute macular neuroretinopathy (AMN) and/or paracentral acute middle maculopathy (PAMM) were reported among patients with COVID-19, presenting scotoma resolved spontaneously in most cases. Among the 26 cases vaccinated with either mRNA or adenoviral vector vaccines for COVID-19 and presenting retinal vascular occlusions, there were more RVO cases than RAO cases, and ocular symptoms mostly occurred within 3 weeks after vaccination. One case presented bilateral AMN and PAMM after COVID-19 vaccination.

Conclusion

Retinal vascular occlusions might be a manifestation of COVID-19, although rare, especially in patients at risk of systemic hypercoagulability and thromboembolism. For COVID-19 vaccines, the causal relationship is controversial because there are few case reports of retinal vascular occlusions after COVID-19 vaccination.

Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, Zhao X, Huang B, Shi W, Lu R, Niu P, Zhan F, Ma X, Wang D, Xu W, Wu G, Gao GF, Tan W (2020) A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med 382:727–733. https://doi.org/10.1056/NEJMoa2001017CrossRefPubMedPubMedCentral

Xie M, Chen Q (2020) Insight into 2019 novel coronavirus - an updated interim review and lessons from SARS-CoV and MERS-CoV. Int J Infect Dis 94:119–124. https://doi.org/10.1016/j.ijid.2020.03.071CrossRefPubMedPubMedCentral

Mai F, Del Pinto R, Ferri C (2020) COVID-19 and cardiovascular diseases. J Cardiol 76:453–458. https://doi.org/10.1016/j.jjcc.2020.07.013CrossRefPubMedPubMedCentral

Berger JR (2020) COVID-19 and the nervous system. J Neurovirol 26:143–148. https://doi.org/10.1007/s13365-020-00840-5CrossRefPubMedPubMedCentral

Lee IC, Huo TI, Huang YH (2020) Gastrointestinal and liver manifestations in patients with COVID-19. J Chin Med Assoc 83:521–523. https://doi.org/10.1097/jcma.0000000000000319CrossRefPubMed

Ali MAM, Spinler SA (2021) COVID-19 and thrombosis: from bench to bedside. Trends Cardiovasc Med 31:143–160. https://doi.org/10.1016/j.tcm.2020.12.004CrossRefPubMed

Terpos E, Ntanasis-Stathopoulos I, Elalamy I, Kastritis E, Sergentanis TN, Politou M, Psaltopoulou T, Gerotziafas G, Dimopoulos MA (2020) Hematological findings and complications of COVID-19. Am J Hematol 95:834–847. https://doi.org/10.1002/ajh.25829CrossRefPubMedPubMedCentral

Wiersinga WJ, Rhodes A, Cheng AC, Peacock SJ, Prescott HC (2020) Pathophysiology, transmission, diagnosis, and treatment of coronavirus disease 2019 (COVID-19): A review. JAMA 324:782–793. https://doi.org/10.1001/jama.2020.12839CrossRefPubMed

Park HS, Byun Y, Byeon SH, Kim SS, Kim YJ, Lee CS (2021) Retinal hemorrhage after SARS-CoV-2 vaccination. J Clin Med 10. https://doi.org/10.3390/jcm10235705

10.

Roshanshad A, Ashraf MA, Roshanshad R, Kharmandar A, Zomorodian SA, Ashraf H (2021) Ocular manifestations of patients with coronavirus disease 2019: a comprehensive review. J Ophthalmic Vis Res 16:234–247. https://doi.org/10.18502/jovr.v16i2.9087CrossRefPubMedPubMedCentral

11.

Nasiri N, Sharifi H, Bazrafshan A, Noori A, Karamouzian M, Sharifi A (2021) Ocular manifestations of COVID-19: a systematic review and meta-analysis. J Ophthalmic Vis Res 16:103–112. https://doi.org/10.18502/jovr.v16i1.8256CrossRefPubMedPubMedCentral

12.

Ng XL, Betzler BK, Testi I, Ho SL, Tien M, Ngo WK, Zierhut M, Chee SP, Gupta V, Pavesio CE, de Smet MD, Agrawal R (2021) Ocular adverse events after COVID-19 vaccination. Ocul Immunol Inflamm 29:1216–1224. https://doi.org/10.1080/09273948.2021.1976221CrossRefPubMed

13.

Marinho PM, Marcos AAA, Romano AC, Nascimento H, Belfort R Jr (2020) Retinal findings in patients with COVID-19. Lancet 395:1610. https://doi.org/10.1016/s0140-6736(20)31014-xCrossRefPubMedPubMedCentral

14.

Vavvas DG, Sarraf D, Sadda SR, Eliott D, Ehlers JP, Waheed NK, Morizane Y, Sakamoto T, Tsilimbaris M, Miller JB (2020) Concerns about the interpretation of OCT and fundus findings in COVID-19 patients in recent Lancet publication. Eye (Lond) 34:2153–2154. https://doi.org/10.1038/s41433-020-1084-9CrossRefPubMed

15.

Bialasiewicz AA, Farah-Diab MS, Mebarki HT (2021) Central retinal vein occlusion occurring immediately after 2nd dose of mRNA SARS-CoV-2 vaccine. Int Ophthalmol 41:3889–3892. https://doi.org/10.1007/s10792-021-01971-2CrossRefPubMedPubMedCentral

16.

Sacconi R, Simona F, Forte P, Querques G (2021) Retinal vein occlusion following two doses of mRNA-1237 (Moderna) immunization for SARS-Cov-2: a case report. Ophthalmol Ther:1–6. https://doi.org/10.1007/s40123-021-00441-3

17.

Lani-Louzada R, Ramos C, Cordeiro RM, Sadun AA (2020) Retinal changes in COVID-19 hospitalized cases. PLoS One 15:e0243346. https://doi.org/10.1371/journal.pone.0243346CrossRefPubMedPubMedCentral

18.

Larochelle R, Koduri V, Chen R, Subramanian PS (2021) Embolic abducens palsy and central retinal artery occlusion in a patient with COVID-19. J Neuroophthalmol. https://doi.org/10.1097/wno.0000000000001291CrossRef

19.

Murchison AP, Sweid A, Dharia R, Theofanis TN, Tjoumakaris SI, Jabbour PM, Bilyk JR (2021) Monocular visual loss as the presenting symptom of COVID-19 infection. Clin Neurol Neurosurg 201:106440. https://doi.org/10.1016/j.clineuro.2020.106440CrossRefPubMed

20.

Ateş O, Yıldırım M, Yıldırım K (2021) Branch retinal artery occlusion in patient with COVID-19: case report. Korean J Ophthalmol 35:484–485. https://doi.org/10.3341/kjo.2021.0008CrossRefPubMedPubMedCentral

21.

Acharya S, Diamond M, Anwar S, Glaser A, Tyagi P (2020) Unique case of central retinal artery occlusion secondary to COVID-19 disease. IDCases 21:e00867. https://doi.org/10.1016/j.idcr.2020.e00867CrossRefPubMedPubMedCentral

22.

Montesel A, Bucolo C, Mouvet V, Moret E, Eandi CM (2020) Case report: central retinal artery occlusion in a COVID-19 patient. Front Pharmacol 11:588384. https://doi.org/10.3389/fphar.2020.588384CrossRefPubMedPubMedCentral

23.

Dumitrascu OM, Volod O, Bose S, Wang Y, Biousse V, Lyden PD (2020) Acute ophthalmic artery occlusion in a COVID-19 patient on apixaban. J Stroke Cerebrovasc Dis 29:104982. https://doi.org/10.1016/j.jstrokecerebrovasdis.2020.104982CrossRefPubMedPubMedCentral

24.

Uzun A, Keles Sahin A, Bektas O (2021) A unique case of branch retinal artery occlusion associated with a relatively mild coronavirus disease 2019. Ocul Immunol Inflamm 29:715–718. https://doi.org/10.1080/09273948.2021.1933071CrossRefPubMed

25.

Ucar F, Cetinkaya S (2021) Central retinal artery occlusion in a patient who contracted COVID-19 and review of similar cases. BMJ Case Rep 14:e244181. https://doi.org/10.1136/bcr-2021-244181CrossRefPubMedPubMedCentral

26.

Turedi N, Onal Gunay B (2021) Paracentral acute middle maculopathy in the setting of central retinal artery occlusion following COVID-19 diagnosis. Eur J Ophthalmol:1120672121995347. https://doi.org/10.1177/1120672121995347

27.

Bapaye MM, Nair AG, Bapaye CM, Bapaye MM, Shukla JJ (2021) Simultaneous bilateral central retinal artery occlusion following COVID-19 infection. Ocul Immunol Inflamm 29:671–674. https://doi.org/10.1080/09273948.2021.1891262CrossRefPubMed

28.

Raj A, Kaur N, Kaur N (2021) Cavernous sinus thrombosis with central retinal artey occlusion in COVID-19: a case report and review of literature. Indian J Ophthalmol 69:1327–1329. https://doi.org/10.4103/ijo.IJO_3770_20CrossRefPubMedPubMedCentral

29.

Been Sayeed SKJ, Chandra Das S, Mahmud R, Moniruzzaman M, Rahman MM (2021) Acute ischemic stroke with central retinal artery occlusion as a rare presentation of COVID-19 disease. Cureus 13:e17469. https://doi.org/10.7759/cureus.17469CrossRefPubMedPubMedCentral

30.

Ozsaygılı C, Bayram N, Ozdemir H (2021) Cilioretinal artery occlusion with paracentral acute middle maculopathy associated with COVID-19. Indian J Ophthalmol 69:1956–1959. https://doi.org/10.4103/ijo.IJO_563_21CrossRefPubMedPubMedCentral

31.

Rao R, Shetty AP, Nagesh CP (2021) Orbital infarction syndrome secondary to rhino-orbital mucormycosis in a case of COVID-19: clinico-radiological features. Indian J Ophthalmol 69:1627–1630. https://doi.org/10.4103/ijo.IJO_1053_21CrossRefPubMedPubMedCentral

32.

Sen M, Honavar SG, Bansal R, Sengupta S, Rao R, Kim U, Sharma M, Sachdev M, Grover AK, Surve A, Budharapu A, Ramadhin AK, Tripathi AK, Gupta A, Bhargava A, Sahu A, Khairnar A, Kochar A, Madhavani A, Shrivastava AK, Desai AK, Paul A, Ayyar A, Bhatnagar A, Singhal A, Nikose AS, Bhargava A, Tenagi AL, Kamble A, Nariani A, Patel B, Kashyap B, Dhawan B, Vohra B, Mandke C, Thrishulamurthy C, Sambare C, Sarkar D, Mankad DS, Maheshwari D, Lalwani D, Kanani D, Patel D, Manjandavida FP, Godhani F, Agarwal GA, Ravulaparthi G, Shilpa GV, Deshpande G, Thakkar H, Shah H, Ojha HR, Jani H, Gontia J, Mishrikotkar JP, Likhari K, Prajapati K, Porwal K, Koka K, Dharawat KS, Ramamurthy LB, Bhattacharyya M, Saini M, Christy MC, Das M, Hada M, Panchal M, Pandharpurkar M, Ali MO, Porwal M, Gangashetappa N, Mehrotra N, Bijlani N, Gajendragadkar N, Nagarkar NM, Modi P, Rewri P, Sao P, Patil PS, Giri P, Kapadia P, Yadav P, Bhagat P, Parekh R, Dyaberi R, Chauhan RS, Kaur R, Duvesh RK, Murthy R, Dandu RV, Kathiara R, Beri R, Pandit R, Rani RH, Gupta R, Pherwani R, Sapkal R, Mehta R, Tadepalli S, Fatima S, Karmarkar S, Patil SS, Shah S, Shah S, Shah S, Dubey S, Gandhi S, Kanakpur S, Mohan S, Bhomaj S, Kerkar S, Jariwala S, Sahu S, Tara S, Maru SK, Jhavar S, Sharma S, Gupta S, Kumari S, Das S, Menon S, Burkule S, Nisar SP, Kaliaperumal S, Rao S, Pakrasi S, Rathod S, Biradar SG, Kumar S, Dutt S, Bansal S, Ravani SA, Lohiya S, Ali Rizvi SW, Gokhale T, Lahane TP, Vukkadala T, Grover T, Bhesaniya T, Chawla U, Singh U, Une VL, Nandedkar V, Subramaniam V, Eswaran V, Chaudhry VN, Rangarajan V, Dehane V, Sahasrabudhe VM, Sowjanya Y, Tupkary Y, Phadke Y (2021) Epidemiology, clinical profile, management, and outcome of COVID-19-associated rhino-orbital-cerebral mucormycosis in 2826 patients in India - Collaborative OPAI-IJO Study on Mucormycosis in COVID-19 (COSMIC), Report 1. Indian J Ophthalmol 69:1670–1692. https://doi.org/10.4103/ijo.IJO_1565_21CrossRefPubMedPubMedCentral

33.

Singh AK, Singh R, Joshi SR, Misra A (2021) Mucormycosis in COVID-19: a systematic review of cases reported worldwide and in India. Diabetes Metab Syndr 15:102146. https://doi.org/10.1016/j.dsx.2021.05.019CrossRefPubMedPubMedCentral

34.

Walinjkar JA, Makhija SC, Sharma HR, Morekar SR, Natarajan S (2020) Central retinal vein occlusion with COVID-19 infection as the presumptive etiology. Indian J Ophthalmol 68:2572–2574. https://doi.org/10.4103/ijo.IJO_2575_20CrossRefPubMedPubMedCentral

35.

Venkatesh R, Reddy NG, Agrawal S, Pereira A (2021) COVID-19-associated central retinal vein occlusion treated with oral aspirin. BMJ Case Rep 14. https://doi.org/10.1136/bcr-2021-242987

36.

Miller CG, Kim BJ (2021) Central retinal vein occlusion in a 46-year-old man with COVID-19: case report and review of the literature. Case Rep Ophthalmol 12:646–652. https://doi.org/10.1159/000517417CrossRefPubMedPubMedCentral

37.

Duff SM, Wilde M, Khurshid G (2021) Branch retinal vein occlusion in a COVID-19 positive patient. Cureus 13:e13586. https://doi.org/10.7759/cureus.13586CrossRefPubMedPubMedCentral

38.

Sheth JU, Narayanan R, Goyal J, Goyal V (2020) Retinal vein occlusion in COVID-19: a novel entity. Indian J Ophthalmol 68:2291–2293. https://doi.org/10.4103/ijo.IJO_2380_20CrossRefPubMedPubMedCentral

39.

Invernizzi A, Pellegrini M, Messenio D, Cereda M, Olivieri P, Brambilla AM, Staurenghi G (2020) Impending central retinal vein occlusion in a patient with coronavirus disease 2019 (COVID-19). Ocul Immunol Inflamm 28:1290–1292. https://doi.org/10.1080/09273948.2020.1807023CrossRefPubMed

40.

Cuadros Sánchez C, Egüen CS, Gutierrez-Ezquerro R, Giralt-Peret L, Fonollosa A (2021) Central retinal vein occlusion presumably associated with lupus anticoagulant induced by SARSCoV-2. Ocul Immunol Inflamm:1–4. https://doi.org/10.1080/09273948.2021.1933077

41.

Gaba WH, Ahmed D, Al Nuaimi RK, Dhanhani AA, Eatamadi H (2020) Bilateral central retinal vein occlusion in a 40-year-old man with severe coronavirus disease 2019 (COVID-19) Pneumonia. Am J Case Rep 21:e927691. https://doi.org/10.12659/ajcr.927691CrossRefPubMedPubMedCentral

42.

Nourinia R, Ghassempour M, Ahmadieh H, Abtahi SH (2021) Branch retinal vein occlusion after COVID-19. J Fr Ophtalmol 44:e441–e443. https://doi.org/10.1016/j.jfo.2021.06.003CrossRefPubMedPubMedCentral

43.

Rego Lorca D, Rouco Fernandez A, Jimenez Santos M, Saenz-Frances F, Burgos-Blasco B, Donate Lopez J (2021) Bilateral retinal vein occlusion and diabetic retinopathy after COVID-19. Acta Ophthalmol 99:e1246–e1248. https://doi.org/10.1111/aos.14718CrossRefPubMed

44.

Yahalomi T, Pikkel J, Arnon R, Pessach Y (2020) Central retinal vein occlusion in a young healthy COVID-19 patient: a case report. Am J Ophthalmol Case Rep 20:100992. https://doi.org/10.1016/j.ajoc.2020.100992CrossRefPubMedPubMedCentral

45.

Finn AP, Khurana RN, Chang LK (2021) Hemi-retinal vein occlusion in a young patient with COVID-19. Am J Ophthalmol Case Rep 22:101046. https://doi.org/10.1016/j.ajoc.2021.101046CrossRefPubMedPubMedCentral

46.

Russe-Russe JR, Alvarez-Betancourt A, Milburn A, Anand P (2021) Hemi-central retinal vein occlusion as a rare manifestation of the hypercoagulable state in COVID-19. BMJ Case Rep 14. https://doi.org/10.1136/bcr-2021-246428

47.

Raval N, Djougarian A, Lin J (2021) Central retinal vein occlusion in the setting of COVID-19 infection. J Ophthalmic Inflamm Infect 11:10. https://doi.org/10.1186/s12348-021-00241-7CrossRefPubMedPubMedCentral

48.

Dansingani KK, Freund KB (2015) Paracentral acute middle maculopathy and acute macular neuroretinopathy: related and distinct entities. Am J Ophthalmol 160:1-3.e2. https://doi.org/10.1016/j.ajo.2015.05.001CrossRefPubMed

49.

Gascon P, Briantais A, Bertrand E, Ramtohul P, Comet A, Beylerian M, Sauvan L, Swiader L, Durand JM, Denis D (2020) Covid-19-associated retinopathy: a case report. Ocul Immunol Inflamm 28:1293–1297. https://doi.org/10.1080/09273948.2020.1825751CrossRefPubMed

50.

Virgo J, Mohamed M (2020) Paracentral acute middle maculopathy and acute macular neuroretinopathy following SARS-CoV-2 infection. Eye (Lond) 34:2352–2353. https://doi.org/10.1038/s41433-020-1069-8CrossRefPubMed

51.

Goyal M, Murthy SI, Annum S (2021) Retinal manifestations in patients following COVID-19 infection: a consecutive case series. Indian J Ophthalmol 69:1275–1282. https://doi.org/10.4103/ijo.IJO_403_21CrossRefPubMedPubMedCentral

52.

Padhy SK, Dcruz RP, Kelgaonkar A (2021) Paracentral acute middle maculopathy following SARS-CoV-2 infection: the D-dimer hypothesis. BMJ Case Rep 14. https://doi.org/10.1136/bcr-2021-242043

53.

Sonmez HK, Polat OA, Erkan G (2021) Inner retinal layer ischemia and vision loss after COVID-19 infection: a case report. Photodiagnosis Photodyn Ther 35:102406. https://doi.org/10.1016/j.pdpdt.2021.102406CrossRefPubMedPubMedCentral

54.

Jonathan GL, Scott FM, Matthew KD (2021) A case of post-COVID-19-associated paracentral acute middle maculopathy and giant cell arteritis-like vasculitis. J Neuroophthalmol 41:351–355. https://doi.org/10.1097/wno.0000000000001348CrossRefPubMed

55.

Abdin AD, Gärtner BC, Seitz B (2022) Central retinal artery occlusion following COVID-19 vaccine administration. Am J Ophthalmol Case Rep 26:101430. https://doi.org/10.1016/j.ajoc.2022.101430CrossRefPubMedPubMedCentral

56.

Sonawane NJ, Yadav D, Kota AR, Singh HV (2022) Central retinal vein occlusion post-COVID-19 vaccination. Indian J Ophthalmol 70:308–309. https://doi.org/10.4103/ijo.IJO_1757_21CrossRefPubMed

57.

Goyal M, Murthy SI, Srinivas Y (2021) Unilateral retinal vein occlusion in a young, healthy male following Sputnik V vaccination. Indian J Ophthalmol 69:3793–3794. https://doi.org/10.4103/ijo.IJO_2412_21CrossRefPubMedPubMedCentral

58.

Endo B, Bahamon S, Martínez-Pulgarín DF (2021) Central retinal vein occlusion after mRNA SARS-CoV-2 vaccination: a case report. Indian J Ophthalmol 69:2865–2866. https://doi.org/10.4103/ijo.IJO_1477_21CrossRefPubMedPubMedCentral

59.

Girbardt C, Busch C, Al-Sheikh M, Gunzinger JM, Invernizzi A, Xhepa A, Unterlauft JD, Rehak M (2021) Retinal vascular events after mRNA and adenoviral-vectored COVID-19 vaccines-a case series. Vaccines (Basel) 9. https://doi.org/10.3390/vaccines9111349

60.

Ikegami Y, Numaga J, Okano N, Fukuda S, Yamamoto H, Terada Y (2021) Combined central retinal artery and vein occlusion shortly after mRNA-SARS-CoV-2 vaccination. QJM 114:884–885. https://doi.org/10.1093/qjmed/hcab287CrossRef

61.

Sugihara K, Kono M, Tanito M (2022) Branch retinal vein occlusion after messenger RNA-based COVID-19 vaccine. Case Rep Ophthalmol 13:28–32. https://doi.org/10.1159/000521838CrossRefPubMedPubMedCentral

62.

Pur DR, Catherine Danielle Bursztyn LL, Iordanous Y (2022) Branch retinal vein occlusion in a healthy young man following mRNA COVID-19 vaccination. Am J Ophthalmol Case Rep 26:101445. https://doi.org/10.1016/j.ajoc.2022.101445CrossRefPubMedPubMedCentral

63.

Shah PP, Gelnick S, Jonisch J, Verma R (2021) Central retinal vein occlusion following BNT162b2 (Pfizer-BioNTech) COVID-19 messenger RNA vaccine. Retin Cases Brief Rep. https://doi.org/10.1097/icb.0000000000001214

64.

Lee S, Sankhala KK, Bose S, Gallemore RP (2022) Combined central retinal artery and vein occlusion with ischemic optic neuropathy after COVID-19 vaccination. Int Med Case Rep J 15:7–14. https://doi.org/10.2147/imcrj.S328931CrossRefPubMedPubMedCentral

65.

Vinzamuri S, Pradeep TG, Kotian R (2021) Bilateral paracentral acute middle maculopathy and acute macular neuroretinopathy following COVID-19 vaccination. Indian J Ophthalmol 69:2862–2864. https://doi.org/10.4103/ijo.IJO_1333_21CrossRefPubMedPubMedCentral

66.

Casagrande M, Fitzek A, Püschel K, Aleshcheva G, Schultheiss HP, Berneking L, Spitzer MS, Schultheiss M (2020) Detection of SARS-CoV-2 in human retinal biopsies of deceased COVID-19 patients. Ocul Immunol Inflamm 28:721–725. https://doi.org/10.1080/09273948.2020.1770301CrossRefPubMed

67.

Bayyoud T, Iftner A, Iftner T, Bartz-Schmidt KU, Ziemssen F, Bösmüller H, Fend F, Rohrbach JM, Ueffing M, Schindler M, Thaler S (2021) Severe acute respiratory syndrome-coronavirus-2: Can it be detected in the retina? PLoS One 16:e0251682. https://doi.org/10.1371/journal.pone.0251682CrossRefPubMedPubMedCentral

68.

Zhang Y, Stewart JM (2021) Retinal and choroidal manifestations of COVID-19. Curr Opin Ophthalmol 32:536–540. https://doi.org/10.1097/icu.0000000000000801CrossRefPubMed

69.

Mir T, Almas T, Kaur J, Faisaluddin M, Song D, Ullah W, Mamtani S, Rauf H, Yadav S, Latchana S, Michaelson NM, Connerney M, Sattar Y (2021) Coronavirus disease 2019 (COVID-19): multisystem review of pathophysiology. Ann Med Surg (Lond) 69:102745. https://doi.org/10.1016/j.amsu.2021.102745CrossRefPubMedPubMedCentral

70.

Levi M, Thachil J, Iba T, Levy JH (2020) Coagulation abnormalities and thrombosis in patients with COVID-19. Lancet Haematol 7:e438–e440. https://doi.org/10.1016/s2352-3026(20)30145-9CrossRefPubMedPubMedCentral

71.

Al-Moujahed A, Boucher N, Fernando R, Saroj N, Vail D, Rosenblatt TR, Moshfeghi DM (2022) Incidence of retinal artery and vein occlusions during the COVID-19 pandemic. Ophthalmic Surg Lasers Imaging Retina 53:22–30. https://doi.org/10.3928/23258160-20211209-01CrossRefPubMed

72.

Modjtahedi BS, Do D, Luong TQ, Shaw J (2022) Changes in the incidence of retinal vascular occlusions after COVID-19 diagnosis. JAMA Ophthalmol 140:523–527. https://doi.org/10.1001/jamaophthalmol.2022.0632CrossRefPubMedPubMedCentral

73.

Marcucci R, Sofi F, Grifoni E, Sodi A, Prisco D (2011) Retinal vein occlusions: a review for the internist. Intern Emerg Med 6:307–314. https://doi.org/10.1007/s11739-010-0478-2CrossRefPubMed

74.

Song P, Xu Y, Zha M, Zhang Y, Rudan I (2019) Global epidemiology of retinal vein occlusion: a systematic review and meta-analysis of prevalence, incidence, and risk factors. J Glob Health 9:010427. https://doi.org/10.7189/jogh.09.010427CrossRefPubMedPubMedCentral

75.

Rahimy E, Sarraf D (2014) Paracentral acute middle maculopathy spectral-domain optical coherence tomography feature of deep capillary ischemia. Curr Opin Ophthalmol 25:207–212. https://doi.org/10.1097/icu.0000000000000045CrossRefPubMed

76.

Bhavsar KV, Lin S, Rahimy E, Joseph A, Freund KB, Sarraf D, Cunningham ET Jr (2016) Acute macular neuroretinopathy: a comprehensive review of the literature. Surv Ophthalmol 61:538–565. https://doi.org/10.1016/j.survophthal.2016.03.003CrossRefPubMed

77.

Azar G, Bonnin S, Vasseur V, Faure C, Salviat F, Clermont CV, Titah C, Farès S, Boulanger E, Derrien S, Couturier A, Duvilliers A, Manassero A, Hage R, Tadayoni R, Behar-Cohen F, Mauget-Faÿsse M (2021) Did the COVID-19 pandemic increase the incidence of acute macular neuroretinopathy? J Clin Med 10. https://doi.org/10.3390/jcm10215038

78.

Domingo RA, Ramos-Fresnedo A, Perez-Vega C, Tripathi S, Pullen MW, Martinez JL, Erben YM, Meschia J, Tawk RG (2022) Cerebral venous thrombosis during the COVID-19 pandemic: a multi-center experience. Clin Neurol Neurosurg 217:107256. https://doi.org/10.1016/j.clineuro.2022.107256CrossRefPubMedPubMedCentral

79.

Tanislav C, Rosenbauer J, Zingel R, Kostev K (2022) No increased incidence of venous thrombosis or pulmonary embolism after SARS-CoV-2 vaccination in Germany. Public Health 207:14–18. https://doi.org/10.1016/j.puhe.2022.03.004CrossRefPubMed

80.

Tu TM, Yi SJ, Koh JS, Saffari SE, Hoe RHM, Chen GJ, Chiew HJ, Tham CH, Seet CYH, Yong MH, Yong KP, Hui AC, Fan BE, Tan BY, Quek AML, Seet RCS, Yeo LLL, Tan K, Thirugnanam UN (2022) Incidence of cerebral venous thrombosis following SARS-CoV-2 infection vs mRNA SARS-CoV-2 vaccination in Singapore. JAMA Netw Open 5:e222940. https://doi.org/10.1001/jamanetworkopen.2022.2940CrossRefPubMedPubMedCentral

81.

Afshar ZM, Barary M, Babazadeh A, Hosseinzadeh R, Alijanpour A, Miri SR, Sio TT, Sullman MJM, Carson-Chahhoud K, Langer F, Ebrahimpour S (2022) SARS-CoV-2-related and Covid-19 vaccine-induced thromboembolic events: a comparative review. Rev Med Virol 32:e2327. https://doi.org/10.1002/rmv.2327CrossRefPubMed

82.

See I, Lale A, Marquez P, Streiff MB, Wheeler AP, Tepper NK, Woo EJ, Broder KR, Edwards KM, Gallego R, Geller AI, Jackson KA, Sharma S, Talaat KR, Walter EB, Akpan IJ, Ortel TL, Urrutia VC, Walker SC, Yui JC, Shimabukuro TT, Mba-Jonas A, Su JR, Shay DK (2022) Case series of thrombosis with thrombocytopenia syndrome after COVID-19 vaccination-United States, December 2020 to August 2021. Ann Intern Med 175:513–522. https://doi.org/10.7326/m21-4502CrossRefPubMed

83.

See I, Su JR, Lale A, Woo EJ, Guh AY, Shimabukuro TT, Streiff MB, Rao AK, Wheeler AP, Beavers SF, Durbin AP, Edwards K, Miller E, Harrington TA, Mba-Jonas A, Nair N, Nguyen DT, Talaat KR, Urrutia VC, Walker SC, Creech CB, Clark TA, DeStefano F, Broder KR (2021) US case reports of cerebral venous sinus thrombosis with thrombocytopenia after Ad26.COV2.S vaccination, March 2 to April 21, 2021. JAMA 325:2448–2456. https://doi.org/10.1001/jama.2021.7517CrossRefPubMed

84.

Patel R, Kaki M, Potluri VS, Kahar P, Khanna D (2022) A comprehensive review of SARS-CoV-2 vaccines: Pfizer, Moderna & Johnson & Johnson. Hum Vaccin Immunother 18:2002083. https://doi.org/10.1080/21645515.2021.2002083CrossRefPubMedPubMedCentral

Titel: Retinal vascular occlusions in COVID-19 infection and vaccination: a literature review
verfasst von: Suji Yeo
Hanju Kim
Jiwon Lee
Jeonghyun Yi
Yoo-Ri Chung
Publikationsdatum: 04.01.2023
Verlag: Springer Berlin Heidelberg
Schlagwort: COVID-19
Erschienen in: Graefe's Archive for Clinical and Experimental Ophthalmology / Ausgabe 7/2023
Print ISSN: 0721-832X
Elektronische ISSN: 1435-702X
DOI: https://doi.org/10.1007/s00417-022-05953-7

Neu im Fachgebiet Augenheilkunde

Metastase in der periokulären Region

Metastasen Leitthema

Orbitale und periokuläre metastatische Tumoren galten früher als sehr selten. Aber mit der ständigen Aktualisierung von Medikamenten und Nachweismethoden für die Krebsbehandlung werden neue Chemotherapien und Strahlenbehandlungen eingesetzt. Die …

Staging und Systemtherapie bei okulären und periokulären Metastasen

Metastasen Leitthema

Metastasen bösartiger Erkrankungen sind die häufigsten Tumoren, die im Auge diagnostiziert werden. Sie treten bei ungefähr 5–10 % der Patienten mit soliden Tumoren im Verlauf der Erkrankung auf. Besonders häufig sind diese beim Mammakarzinom und …

CME: Wundheilung nach Trabekulektomie

Trabekulektomie CME-Artikel

Wird ein Glaukom chirurgisch behandelt, ist die anschließende Wundheilung von entscheidender Bedeutung. In diesem CME-Kurs lernen Sie, welche Pathomechanismen der Vernarbung zugrunde liegen, wie perioperativ therapiert und Operationsversagen frühzeitig erkannt werden kann.

„standard operating procedures“ (SOP) – Vorschlag zum therapeutischen Management bei periokulären sowie intraokulären Metastasen

Metastasen Leitthema

Peri- sowie intraokuläre Metastasen sind insgesamt gesehen selten und meist Zeichen einer fortgeschrittenen primären Tumorerkrankung. Die Therapie ist daher zumeist palliativ und selten kurativ. Zudem ist die Therapiefindung sehr individuell. Die …

Update Augenheilkunde

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Retinal vascular occlusions in COVID-19 infection and vaccination: a literature review

Abstract

Purpose

Methods

Results

Conclusion

Neu im Fachgebiet Augenheilkunde

Metastase in der periokulären Region

Staging und Systemtherapie bei okulären und periokulären Metastasen

CME: Wundheilung nach Trabekulektomie

„standard operating procedures“ (SOP) – Vorschlag zum therapeutischen Management bei periokulären sowie intraokulären Metastasen

Update Augenheilkunde

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Abstract

Purpose

Methods

Results

Conclusion

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 7/2023

New technology using crystalline lens autofluorescence for presbyopia and cataract grading

Re: Cazana et al.: A comparison of long-term results after Baerveldt 250 implantation in advanced uveitic vs. other forms of glaucoma. Graefes Arch Clin Exp Ophthalmol. 2018 Nov;256(11):2069–2073. doi: 10.1007/s00417-018–4106-6. Epub 2018 Aug 23

Letter to the editor regarding “A novel tandem duplication of PRDM13 in a Chinese family with North Carolina macular dystrophy”

Comitant strabismus etiology: extraocular muscle integrity and central nervous system involvement—a narrative review

A letter to the editor regarding “A novel tandem duplication of PRDM13 in a Chinese family with North Carolina macular dystrophy”

Circumferential (360°) trabeculotomy for steroid-induced glaucoma in adults

Neu im Fachgebiet Augenheilkunde

Metastase in der periokulären Region

Staging und Systemtherapie bei okulären und periokulären Metastasen

CME: Wundheilung nach Trabekulektomie

„standard operating procedures“ (SOP) – Vorschlag zum therapeutischen Management bei periokulären sowie intraokulären Metastasen

Update Augenheilkunde